Maternal third dose of BNT162b2 mRNA vaccine and risk of infant COVID-19 hospitalization - Nature Medicine
Analysis from a population cohort in Israel found that a third booster dose of the BNT162b2 mRNA vaccine in mothers before or during pregnancy was associated with greater protection against COVID-19 hospitalization in their infants compared to two doses.


